Beneficial effects of L-Arginine in patients hospitalized for COVID-19: New insights from a randomized clinical trial

We have recently demonstrated in a double-blind randomized trial the beneficial effects of L-Arginine in patients hospitalized for COVID-19. We hypothesize that one of the mechanisms underlying the favorable effects of L-Arginine is its action on inflammatory cytokines. To verify our hypothesis, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Trimarco, Valentina, Izzo, Raffaele, Lombardi, Angela, Coppola, Antonietta, Fiorentino, Giuseppe, Santulli, Gaetano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928676/
https://www.ncbi.nlm.nih.gov/pubmed/36804278
http://dx.doi.org/10.1016/j.phrs.2023.106702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928676/
https://www.ncbi.nlm.nih.gov/pubmed/36804278
http://dx.doi.org/10.1016/j.phrs.2023.106702

Ejemplares similares